Literature DB >> 19911421

Prognostic relevance of DNA copy number changes in colorectal cancer.

George Poulogiannis1, Koichi Ichimura, Rifat A Hamoudi, Feijun Luo, Suet Y Leung, Siu T Yuen, David J Harrison, Andrew H Wyllie, Mark J Arends.   

Abstract

In a study of 109 colorectal cancers, DNA copy number aberrations were identified by comparative genomic hybridization using a DNA microarray covering the entire genome at an average interval of less than 1 Mbase. Four patterns were revealed by unsupervised clustering analysis, one of them associated with significantly better prognosis than the others. This group contained tumours with short, dispersed, and relatively few regions of copy number gain or loss. The good prognosis of this group was not attributable to the presence of tumours showing microsatellite instability (MSI-H). Supervised methods were employed to determine those genomic regions where copy number alterations correlate significantly with multiple indices of aggressive growth (lymphatic spread, recurrence, and early death). Multivariate analysis identified DNA copy number loss at 18q12.2, harbouring a single gene, BRUNOL4 that encodes the Bruno-like 4 splicing factor, as an independent prognostic indicator. The data show that the different patterns of DNA copy number alterations in primary tumours reveal prognostic information and can aid identification of novel prognosis-associated genes. Copyright 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19911421     DOI: 10.1002/path.2640

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

Review 1.  Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Authors:  Katsuhiko Nosho; Yoshifumi Baba; Noriko Tanaka; Kaori Shima; Marika Hayashi; Jeffrey A Meyerhardt; Edward Giovannucci; Glenn Dranoff; Charles S Fuchs; Shuji Ogino
Journal:  J Pathol       Date:  2010-12       Impact factor: 7.996

2.  Genomic instability measured by inter-(simple sequence repeat) PCR and high-resolution microsatellite instability are prognostic of colorectal carcinoma survival after surgical resection.

Authors:  Bruce M Brenner; Helen Swede; Beth A Jones; Garth R Anderson; Daniel L Stoler
Journal:  Ann Surg Oncol       Date:  2011-04-13       Impact factor: 5.344

3.  aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Authors:  Yoshihiko Fujita; Masataka Taguri; Kentaro Yamazaki; Junji Tsurutani; Kazuko Sakai; Takahiro Tsushima; Michitaka Nagase; Hiroshi Tamagawa; Shinya Ueda; Takao Tamura; Yasushi Tsuji; Kohei Murata; Koichi Taira; Tadamichi Denda; Toshikazu Moriwaki; Sadao Funai; Takako Eguchi Nakajima; Kei Muro; Akihito Tsuji; Motoki Yoshida; Koichi Suyama; Takuya Kurimoto; Naotoshi Sugimoto; Eishi Baba; Nobuhiko Seki; Mikio Sato; Takaya Shimura; Narikazu Boku; Ichinosuke Hyodo; Takeharu Yamanaka; Kazuto Nishio
Journal:  Oncologist       Date:  2018-11-13

4.  PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Authors:  George Poulogiannis; Rebecca E McIntyre; Maria Dimitriadi; John R Apps; Catherine H Wilson; Koichi Ichimura; Feijun Luo; Lewis C Cantley; Andrew H Wyllie; David J Adams; Mark J Arends
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

Review 5.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

6.  Development of GMDR-GPU for gene-gene interaction analysis and its application to WTCCC GWAS data for type 2 diabetes.

Authors:  Zhixiang Zhu; Xiaoran Tong; Zhihong Zhu; Meimei Liang; Wenyan Cui; Kunkai Su; Ming D Li; Jun Zhu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.

Authors:  Leonie J M Mekenkamp; Jolien Tol; Jeroen R Dijkstra; Inge de Krijger; M Elisa Vink-Börger; Shannon van Vliet; Steven Teerenstra; Eveline Kamping; Eugène Verwiel; Miriam Koopman; Gerrit A Meijer; J Han Jm van Krieken; Roland Kuiper; Cornelis J A Punt; Iris D Nagtegaal
Journal:  BMC Cancer       Date:  2012-07-17       Impact factor: 4.430

8.  A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.

Authors:  Tao Xie; Giovanni D' Ario; John R Lamb; Eric Martin; Kai Wang; Sabine Tejpar; Mauro Delorenzi; Fred T Bosman; Arnaud D Roth; Pu Yan; Stephanie Bougel; Antonio Fabio Di Narzo; Vlad Popovici; Eva Budinská; Mao Mao; Scott L Weinrich; Paul A Rejto; J Graeme Hodgson
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.

Authors:  María González-González; Luís Muñoz-Bellvis; Carlos Mackintosh; Celia Fontanillo; M Laura Gutiérrez; M Mar Abad; Oscar Bengoechea; Cristina Teodosio; Emilio Fonseca; Manuel Fuentes; Javier De Las Rivas; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer.

Authors:  Elizabeth Day; George Poulogiannis; Frank McCaughan; Shani Mulholland; Mark J Arends; Ashraf E K Ibrahim; Paul H Dear
Journal:  Int J Exp Pathol       Date:  2013-04-18       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.